Regulation 53 Amendments to Schedule 2
Schedule 2 (applications in respect of pharmaceutical lists and the procedures to be followed) is amended as follows.
In Part 1 (information to be included in routine and excepted applications), in paragraph 9 (Undertakings)f1, in sub-paragraph (1)—
in paragraph (c)(ii), after “perform all the activities at” insert “or from”; and
in paragraph (d)(i), after “does commission the services” insert “at or”.
In Part 5 (notification, taking effect of decisions and rights of appeal to the Secretary of State)—
in paragraph 29 (template notice of commencement to be included with a notice of decision)f2—
in sub-paragraph (b), after “are to be provided” insert “at or”, and
in sub-paragraph (d), after “provision of those services at” insert “or from”;
in paragraph 29A (template notice of consolidation)f3, in sub-paragraph (2)—
in paragraph (b), after “of the premises at” insert “or from”,
in paragraph (c), after “cease being provided at” insert “or from”, and
in paragraph (d), after “address of the premises at” insert “or from”;
in paragraph 33 (conditional grant in cases relating to future needs or future improvements or better access)f4, in sub-paragraph (2)—
after “pharmaceutical services are not provided at” insert “or from”, and
after “the application relates (or at” insert “or from”;
in paragraph 34 (taking of effect of listing decisions: general)f5—
in sub-paragraph (1)(b)—
in sub-paragraph (i), after “additional premises” insert “at or”,
in sub-paragraph (ii), after “different premises, and at” insert “or from”, and
in sub-paragraph (iii), after “to provide,” insert “at or”, and
in sub-paragraph (2), after “was made and at” insert “or from”.
Annotations
Footnotes
- f1
-
Paragraph 9 has been amended by S.I. 2016/1077 and 2023/1071.
- f2
-
Paragraph 29 has been amended by S.I. 2016/1077 and 2023/1071.
- f3
-
Paragraph 29A was inserted by S.I. 2016/1077 and has been amended by S.I. 2023/1071.
- f4
-
Paragraph 33 has been amended by S.I. 2023/1071.
- f5
-
Paragraph 34 has been amended by S.I. 2016/1077, 2020/885 and 1126, and 2023/479 and 1071.